Baxter to train 100 surgeons by year-end in use of minimally invasive saphenous vein graft system.
This article was originally published in The Gray Sheet
Executive Summary
BAXTER TO TRAIN 100 PHYSICIANS IN USE OF SIDE BRANCH OCCLUSION SYSTEM by year-end, the firm says. Baxter has contracted Denver, Colorado-based Education Design Inc. to conduct 10 one-day clinics to teach doctors how to use the minimally invasive saphenous vein graft (SVG) system for treating peripheral vascular disease. The clinics, to be conducted at various U.S. locations, each will enroll 10 doctors. Baxter says the eight-hour training session will cost $950 per physician.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.